野火烟雾对加利福尼亚州喘控制的影响:微模拟方法
Sigal Maya1, Neeta Thakur2, Tarik Benmarhnia3
1Philip R. Lee Institute for Health Policy Studies University of California San Francisco San Francisco CA USA.
GeoHealth
|October 7, 2024
概括
野火烟雾显著恶化了喘控制,并增加了喘患者的医疗保健使用和成本. 这种模拟突出了喘患者暴露于烟雾的严重健康和经济负担.
科学领域:
- 环境健康 环境健康
- 呼吸系统医学 呼吸系统医学
- 卫生经济学 卫生经济学
背景情况:
- 野火烟雾暴露会对先前患有喘的人产生负面影响.
- 烟雾中的颗粒物加剧了喘控制,导致急性事件和增加了卫生资源利用率 (HRU).
- 现有的研究在很大程度上是回顾性的,限制了喘控制和HRU因烟雾暴露而变化的预测.
研究的目的:
- 建模和量化野火烟雾暴露对喘控制,恶化,HRU和成本的影响.
- 在野火事件期间和之后,在16周的时间内预测喘结果的变化.
- 建立一个理解喘影响的框架,并为公共卫生政策提供信息.
主要方法:
- 开发了一种微模拟模型,对5000名患有喘的加利福尼亚人进行了微模拟.
- 该模型计算了喘控制分布,恶化风险,HRU和成本结果的变化.
- 模型校准使用了关于喘控制和增加HRU野火后暴露的经验数据.
主要成果:
- 在没有烟雾的情况下,48%的队列患有控制良好的喘;在两周暴露于烟雾后,这一比例下降到27%.
- 野火烟雾暴露导致急性医疗利用率增加4%.
- 估计601,250美元的额外医疗费用和8个更少的质量调整寿命年被观察到超过16周.
结论:
- 野火烟雾显著增加了喘患者的健康和经济负担.
- 这些发现与经验证据一致,验证了模拟的方法.
- 这项研究提供了一个框架,以告知公共卫生政策,以减轻野火烟雾的危害,并提高喘患者的性.
更多相关视频
10:37Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
13.2K
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
22.4K
相关概念视频
Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
358
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
358
Inhaled Medications
239
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
239
